Kolexia
Mitry Jean-Emmanuel
Gastro-entérologie
Centre Paoli-Calmettes
Marseille, France
152 Activités
18 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Tumeurs du pancréas Métastase tumorale Tumeurs du poumon Carcinomes Tumeurs du côlon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules

Industries

Pierre Fabre
13 collaboration(s)
Dernière en 2023
Servier
8 collaboration(s)
Dernière en 2023
VIATRIS MEDICAL
4 collaboration(s)
Dernière en 2022
Amgen
4 collaboration(s)
Dernière en 2022

Dernières activités

ALEX: Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer
Essai Clinique (Roche)   12 février 2024
Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review.
Frontiers in oncology   08 janvier 2024
Organ sparing to cure stage IV rectal cancer: A case report and review of literature.
World journal of gastrointestinal surgery   20 décembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
Assessment of biological effect of nab-paclitaxel combined with gemcitabine, using contrast enhanced ultrasonography and elastography, in advanced pancreatic ductal carcinoma: A single-center pilot study.
Endoscopic ultrasound   31 octobre 2023
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.
Annals of gastroenterology   30 octobre 2023
Peak Risk of Recurrence Occurs during the First Two Years after a Pancreatectomy in Patients Receiving Neoadjuvant FOLFIRINOX.
Cancers   26 octobre 2023
138P Precision medicine phase II study evaluating the efficacy of olaparib in patients with progressive solid cancers and carriers of homologous recombination repair genes alterations
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA network open   05 septembre 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments.
Brachytherapy   06 mai 2023